Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well...
This clears up absolutely nothing.
Bgen is no longer part of the BCA?
I have no idea what is going on.
https://finance.yahoo.com/news/sagaliam-acquisition-corp-announces-novation-120000626.html
I got rid of the constant harassment by clicking on the button to ignore D***89.
That’s a new one. Calling a post misleading bc he linked the actual company otc filings lmao. Unreal.
Yep. That's what I'm trying to do.
Thanks for posting a link. So helpful. Doesn’t prove a damn thing since current management is dishonest. Let’s dig deeper and not mislead…
And… why do you care…
Wow. Where are the analytics! You seriously believe this filing is accurate and honest? Sheesh
It's funny that James Zimbler is not mentioned in the annual report. I know he is part of the lawsuits. Is he no longer part of Enzolytics, Inc.? Did the new CEO finally fix that glitch with payroll and get the problem resolved?
Why are you here or will you be one of the ones selling ? GLTA
If you still believe in *holding* this *investment* after today's filing, you're clinically stupid lol
Yea…… huge sell off coming tomorrow!
I was using page 25 showing they hold thoses shares just that they have been removed as officers of the company. If they had converted and sold off we should have had a filing of them doing so. Thye at least didn't sell according to this thru Dec 2023 and up to March 2024 which show removal from office not shares that can be converted to common. Now we need the July filings to see if they still remain on filings as owners of more than the 5% and still have a stake in ENZOLYTICS. If they haven't sold of shares then that is showing they still think value is here of some sort.
So what is your overall take on this filing. I am seeing that the B series are still outstanding ?
When was the dividend anything other than SAGA shares? No one disputed that. So it is an absolute.
Yep Charles , Chandra and Joseph C all REMOVED, right on PAGE 25, with this March 2024 dates , REMOVED
https://www.otcmarkets.com/otcapi/company/financial-report/398912/content
--
Now look for OTC PROFILE page to be updated with this being out and another updated Attorney Letter to get back to Pink Current.
-
Charles S.
Cotropia
CEO/Director (removed on
3-25-2024)
Heath, Texas 68,143,334 Series B 15.39
---
Joseph
Cotropia
CSO (removed on 3-25-
2024)
College
Station, Texas
68,143,334 Series B 15.39
===
Gaurav
Chandra
COO (Removed on March
25, 2024)
Cape Town,
South Africa
68,143,332 Series B 15.39
According to the company it was. And that includes a life long lawyer who was with them at the time they completed it. So I think it’s safe to say that it was. Highly doubt all these guys are continuing forward with all the scrutiny on it if they knew it was illegal from the start. Especially not Charles as a life long lawyer. That tells me that whatever fine print they tossed into it made it technically legal. Whether it met the nasdaq requirements is moot now.
You're speaking in absolutes.
Was the saga deal legal?
Glad there’s now finally confirmation for those still unwilling to believe that Charles and Chandra are both officially gone.
You were never getting money. You were getting SAGA shares. Which it appears you’ll still be getting.
All these subjective IMO's out there , is nonsense .. go with the facts and disclosures and remember I post the links for one to check.
--
New Change of Control filed today . CC and Chandra are not listed in accepting any role or for that mater Joe C.
https://www.otcmarkets.com/otcapi/company/financial-report/398927/content
--
Annual is out now today also filed. remember this is for year end 2023 , HOWEVER, NOTE page 25 shows for SURE CC is out, Chandra is out , Joe C is out . Also all those folks on the share disclosure do not (any longer show any COMMON SHARES !!) on preferred B .
https://www.otcmarkets.com/otcapi/company/financial-report/398912/content
ENZC said all kinds of shit but you cant pick and choose only the things that fit your story.Even if you only get a partial win or return you can write the total off as total tax loss.
450 million was the exchange as I remember.
If that’s the case then Yes. Show me the money!
No they don’t, it was sold to SAGA under the subs in the competed deal. Which even the new ENZC ceo is telling you in a PR was completed bc they are contacting FINRA to commence with the distribution of the dividend shares. The now worthless SAGA dividend shares, but none the less, they’ll be handing them out.
And like some of us repeatedly warned last summer, they told all shareholders at that time, well in advance, there would be “no assets, no operations” left in ENZC after the completion of the sale.
Here we are now, “no assets” left under ENZC and people are screaming to the sky for lawsuits. Get real people.
All the AI used to find the immutable virus scape was done 3 years ago. ENZC owns that.
Actually, as I recall, Chandra completed his AI model and design layouts, as a result of the ENZC-Intel Partnership, many months before Samsung signed that old production deal with ENZC.
But it is a Samsung campus in Korea, that houses the alleged MAB-TECH corporation office.
Curious.
Very good point Dog, but it seems so contrary to reality on the ground right now. I hope you are right. I just worry Sharabura will hide with the "It was out of our hands" excuse if SAGA is dropped, closed and Kostiner goes and opens a new Funding SPAC company, which would void everything.
Oh, the landmines in OTC:PINK land.....storm those beaches men....!
I'll do that, but currently, I don't have the funds to set up the case. Going after a PINK that took in more than five figures in shareholder money is hard to prosecute, so it would take a crowd-fund or something to get it off the ground.
Chandra, Drama Queen of the Medical Officers, we shall see.
We're supposed to have some Patent News by then, perhaps not a full approval, but a decent progress-made kind of thing. But with the current CEO's last PR, it seems they don't care about the Patents and IP's SAGA allegedly has. Who knows....(?)
The moment the corrupt doc starts to hear a lawsuit he will start to talk. That’s how this corrupt work. They take as long as the sheep just go along! Fk them
We are investors in a company, the officers of such are not allowed to move on and take its findings, developments and start another company. Unless they buy it!
Dr. Chandra just now on X: “You will hear from me at the “right” time.”
What did I post that was inaccurate?
No prob, it’s clearly hard to keep track with all the back and forth here at times.
I’m not stating that some type of shareholder lawsuit with damages awarded is impossible.
What I’m countering with facts is the moronic false notion that as a public shareholder you are entitled to any ownership of their products, assets or patents etc developed under their time as ENZC, as was previously claimed here for days now.
You don’t have any rights as a public shareholder to claim their products, assets, patents, etc. Which was what Achilles has been claiming and others like you are backing those claims.
I'm sorry I was being sarcastic. I'm not trying to twist this in any direction, good or bad. I also apologize for my last reply to your response to me as I misread what you posted. I think we are both on the same page.
I’m not attempting anything other than posting facts on this board to counter the false and misleading bullshit constantly posted, which I’ve done for over three years. People can take it as they wish and do what they choose.
Many people have already lost their ass here, so giving them facts to weigh on before others lead them into a worthless shareholder lawsuit to suffer more losses, is reasonable in my view.
What you posted isn't close to being accurate and ENZC isn't close to uplisting to an a exchange - read the listing requirements for Nasdaq.
From the OTCM:
"FINANCIAL REPORTING
Reporting Status
Alternative Reporting Standard"
Which means they don't report to the SEC. This shows how little you know about securities law.
ENZC hasn't filed a registration statement - either a Form 10 or an S-1.
And the OTCQB isn't uplisting - that is a tier created by the OTCM as another income stream - it is meaningless hype.
The OTCM isn't a regulator or an exchange - they are a public for profit PR company.
"An OTC that is not SEC reporting does not report according to the SEC guidelines? They had audited financials which would have led to uplisting. The shareholder meeting happened, how did you vote?"
The common shareholders didn't vote and the insiders did exactly what they wanted to do.
The shareholder meeting was only for insiders, don’t try to twist this bs any further than it’s already being twisted. They gave no public notice of any shareholders vote.
Apparently not based on some of the moronic posts made here.
They are trying their best to discourage a legal challenge. Wonder why. A few more years in court would delay their corruption!
It apparent to me you both are trying to talk people out of building a legal case. Wonder why. Chandra or Charles must be paying for your time.
Followers
|
1245
|
Posters
|
|
Posts (Today)
|
13
|
Posts (Total)
|
200046
|
Created
|
01/07/10
|
Type
|
Free
|
Moderators Homebrew Timing101 archilles SeniorApollo |
Independent Valuation Report Pre Clinical Studies
Investments
___________________________________________________________________________________
Press Release July 20-2021
Enzolytics Announces the Signing of a Letter of Intent with Creative Biolabs, Inc.
for Licensing and Commercialization of anti-HTLV-1 Monoclonal Antibodies
https://www.creative-biolabs.com/
https://finance.yahoo.com/news/enzolytics-announces-signing-letter-intent-113000339.htm
________________________________________
Press release July 21-2021
Enzolytics and Lonza Bioscience Combine Technologies to Fast-track Development and
Production of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibodies produced by Enzolytics
https://www.lonza.com/
https://www.bloomberg.com/press-releases/2021-07-21/enzolytics-and-lonza-bioscience-combine-technologies-to-fast-track-development-and-production-of-anti-hiv-and-anti-sar
_________________________________________
July 22 INTERVIEW
with
James Hicks, Charles Cotropia and Gurav Chandra
http://www.youtube.com/watch?v=mdljO9VLgj0
______________________________________________________________
COLLEGE STATION, TX August 25, 2021
Important Excerpt from this news progress update.
>>>>>><<<<<<
"The monoclonal antibodies being produced by Enzolytics against the CoronaVirus target 19 conserved immutable sites on the virus, sites which the Company has now confirmed are conserved sites not only on the initial virus strains but also existing in the Delta and Lambda variants, as well as in the Alpha, Beta and Gamma variants."
Enzolytics Inc. and Samsung Biologics Announce
Development and Manufacturing Agreement for Anti-
HIV and Anti-SARS-CoV-2
Important Excerpt from this news progress update.
>>>>>><<<<<<
"Samsung Biologics (KRX: 207940. K.S.), a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development company committed to commercializing multiple proprietary therapeutics to treat debilitating infectious diseases, announced the signing of a strategic CDMO partnership agreement."_______
2000 North Central Expressway
Plano, TX 75074
972-292-9414
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |